223 related articles for article (PubMed ID: 30082484)
1. Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor.
Hong D; Fritz AJ; Finstad KH; Fitzgerald MP; Weinheimer A; Viens AL; Ramsey J; Stein JL; Lian JB; Stein GS
Mol Cancer Res; 2018 Dec; 16(12):1952-1964. PubMed ID: 30082484
[TBL] [Abstract][Full Text] [Related]
2. RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells.
Fritz AJ; Hong D; Boyd J; Kost J; Finstaad KH; Fitzgerald MP; Hanna S; Abuarqoub AH; Malik M; Bushweller J; Tye C; Ghule P; Gordon J; Frietze S; Zaidi SK; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2020 Oct; 235(10):7261-7272. PubMed ID: 32180230
[TBL] [Abstract][Full Text] [Related]
3. Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition.
Hong D; Messier TL; Tye CE; Dobson JR; Fritz AJ; Sikora KR; Browne G; Stein JL; Lian JB; Stein GS
Oncotarget; 2017 Mar; 8(11):17610-17627. PubMed ID: 28407681
[TBL] [Abstract][Full Text] [Related]
4. Identification of tRNA-derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancer.
Farina NH; Scalia S; Adams CE; Hong D; Fritz AJ; Messier TL; Balatti V; Veneziano D; Lian JB; Croce CM; Stein GS; Stein JL
J Cell Physiol; 2020 Jun; 235(6):5318-5327. PubMed ID: 31919859
[TBL] [Abstract][Full Text] [Related]
5. Runx1 is associated with breast cancer progression in MMTV-PyMT transgenic mice and its depletion in vitro inhibits migration and invasion.
Browne G; Taipaleenmäki H; Bishop NM; Madasu SC; Shaw LM; van Wijnen AJ; Stein JL; Stein GS; Lian JB
J Cell Physiol; 2015 Oct; 230(10):2522-32. PubMed ID: 25802202
[TBL] [Abstract][Full Text] [Related]
6. ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer.
Zhang J; Zhou C; Jiang H; Liang L; Shi W; Zhang Q; Sun P; Xiang R; Wang Y; Yang S
Cell Death Dis; 2017 Apr; 8(4):e2732. PubMed ID: 28383555
[TBL] [Abstract][Full Text] [Related]
7. RUNX1-dependent mechanisms in biological control and dysregulation in cancer.
Hong D; Fritz AJ; Gordon JA; Tye CE; Boyd JR; Tracy KM; Frietze SE; Carr FE; Nickerson JA; Van Wijnen AJ; Imbalzano AN; Zaidi SK; Lian JB; Stein JL; Stein GS
J Cell Physiol; 2019 Jun; 234(6):8597-8609. PubMed ID: 30515788
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.
Browne G; Dragon JA; Hong D; Messier TL; Gordon JA; Farina NH; Boyd JR; VanOudenhove JJ; Perez AW; Zaidi SK; Stein JL; Stein GS; Lian JB
Tumour Biol; 2016 Jul; 37(7):8825-39. PubMed ID: 26749280
[TBL] [Abstract][Full Text] [Related]
9. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
10. RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.
Chimge NO; Little GH; Baniwal SK; Adisetiyo H; Xie Y; Zhang T; O'Laughlin A; Liu ZY; Ulrich P; Martin A; Mhawech-Fauceglia P; Ellis MJ; Tripathy D; Groshen S; Liang C; Li Z; Schones DE; Frenkel B
Nat Commun; 2016 Feb; 7():10751. PubMed ID: 26916619
[TBL] [Abstract][Full Text] [Related]
11. RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes.
Recouvreux MS; Grasso EN; Echeverria PC; Rocha-Viegas L; Castilla LH; Schere-Levy C; Tocci JM; Kordon EC; Rubinstein N
Oncotarget; 2016 Feb; 7(6):6552-65. PubMed ID: 26735887
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth.
Werden SJ; Sphyris N; Sarkar TR; Paranjape AN; LaBaff AM; Taube JH; Hollier BG; Ramirez-Peña EQ; Soundararajan R; den Hollander P; Powell E; Echeverria GV; Miura N; Chang JT; Piwnica-Worms H; Rosen JM; Mani SA
Oncogene; 2016 Nov; 35(46):5977-5988. PubMed ID: 27292262
[TBL] [Abstract][Full Text] [Related]
14. Connexin46 Expression Enhances Cancer Stem Cell and Epithelial-to-Mesenchymal Transition Characteristics of Human Breast Cancer MCF-7 Cells.
Acuña RA; Varas-Godoy M; Herrera-Sepulveda D; Retamal MA
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830485
[TBL] [Abstract][Full Text] [Related]
15. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
16. Schlafen12 Reduces the Aggressiveness of Triple Negative Breast Cancer through Post-Transcriptional Regulation of ZEB1 That Drives Stem Cell Differentiation.
Al-Marsoummi S; Vomhof-DeKrey E; Basson MD
Cell Physiol Biochem; 2019; 53(6):999-1014. PubMed ID: 31838790
[TBL] [Abstract][Full Text] [Related]
17. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
[TBL] [Abstract][Full Text] [Related]
18. Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.
Piggott L; Omidvar N; Martí Pérez S; French R; Eberl M; Clarkson RW
Breast Cancer Res; 2011 Sep; 13(5):R88. PubMed ID: 21914219
[TBL] [Abstract][Full Text] [Related]
19. Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1.
Jiang H; Zhou C; Zhang Z; Wang Q; Wei H; Shi W; Li J; Wang Z; Ou Y; Wang W; Wang H; Zhang Q; Sun W; Sun P; Yang S
Nat Commun; 2020 Oct; 11(1):5129. PubMed ID: 33046710
[TBL] [Abstract][Full Text] [Related]
20. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1.
Gao Y; Zhao Y; Zhang J; Lu Y; Liu X; Geng P; Huang B; Zhang Y; Lu J
Sci Rep; 2016 Jan; 6():19874. PubMed ID: 26813495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
